This recognition means a great deal to us. VLAIO plays a crucial role as a catalyst of the strong and vibrant Flemish biotech ecosystem, empowering innovative companies to turn bold scientific ideas into real-world impact. We are genuinely proud to…
We’re exited to share that GIOS Biostructures will be present at the Protein Structure Determination in Industry (PSDI) 2025 conference. A premier event bringing together leading minds in structural biology, biophysics, and drug discovery. Join us as we connect, collaborate…
Protein design/engineering has entered a new era, fueled by the rise of reliable AI-based methods. This shift has transformed the design process into a powerful loop of scaffold generation, sequence prediction, and structural validation.🔹 Scaffold generation allows us to create…
At GIOS Biostructures, we don’t just study proteins, we design them from scratch. With our de novo protein design service, we create custom scaffolds and structures tailored to your target or application, using advanced neural networks and GPU-powered computation. Our…
Fragment-based screening is a powerful approach to early-stage drug discovery, using small, well-soluble organic molecules to efficiently explore chemical space. Thanks to their simplicity and affordability, fragment libraries are accessible even to the smallest biotech companies. Traditionally, fragments are screened…
At GIOS Biostructures, we take purified proteins and deliver high-resolution 3D structures through our automated crystallography platform and synchrotron access. From crystallization screening and optimization to X-ray data collection and structure refinement, every step is designed for speed, accuracy, and…
Every successful structural or functional study starts with a reliable source of protein. At GIOS Biostructures, we begin by translating your gene of interest into high-quality protein through a robust, reproducible pipeline. This includes custom cloning, optimized expression in suitable…
We are thrilled to announce the launch of GIOS Biostructures, a cutting-edge structural biology CRO. Our mission is to accelerate drug discovery by providing high-quality, end-to-end services to pharmaceutical companies, biotechnology firms and academic laboratories engaged in drug development, biological…
We’re excited to announce that you can now connect with us on LinkedIn!Follow us to stay up to date with our latest news.
We’re thrilled to announce the official launch of GIOS Biostructures, a new CRO dedicated to solving structural biology problems of our customers. Based in Belgium, we’re here to bring our expertise and provide services to the biochemistry and pharmacology companies…